|
[an error occurred while processing this directive]
Trade-Related Aspects of Intellectual Property Rights and Access
to Medicines
BNA's Web Watch is prepared by Laura
Gordon-Murnane. E-mail suggestions for future weekly topics
always welcome.
Federal Government
Department of State - Office of the U.S.
Trade Representative
U.S.
Announces Interim Plan to Help Poor Countries fight HIV/AIDS and
other Health Crises in Absence of WTO Consensus United States
Calls on Other WTO Members to Join in Individually Implementing
the Doha Declaration on the TRIPS Agreement and Public Health
Department of Treasury
Paragraph
6 of the Doha Declaration on TRIPS and Public Health
Second
Communication from the United States on Paragraph 6 of the Doha
Declaration on TRIPS and Public Health
International Organizations
European Union
EU
seeks to break the current deadlock on WTO access to medicines:
a multilateral solution is needed Brussels (9 January 2003)
Trade and Development - Access
to essential medicines Main elements of the Chair's 16 December
2002 draft compromise decision (Perez Motta text) Brussels,
9 January 2003
World Health Organization
WTO
Agreements and Public Health — A joint study by WHO and the
WTO Secretariat (August 2002)
Implications
of the Doha Declaration on the TRIPS Agreement and Public Health
WHO
Medicines Strategy: Framework for Action in Essential Drugs and
Medicines Policy 2000–2003
The
Rationale of Essential Medicines
The WHO Model List of Essential Medicines (formerly Essential Drugs
List or EDL)
The 12th Model List of Essential Medicines
Introductory
text | Core
list | Complementary
list | Antiviral
medicines only | By
ATC Classification
World Trade Organization
TRIPS Agreement - The
full text of the TRIPS Agreement
TRIPS
material on the WTO website
Nongovernmental Organizations
The Commission on Intellectual Property Rights
Integrating
Intellectual Property Rights and Development Policy Report of the
Commission on Intellectual Property Rights
London (September 2002)
Commission on Macroeconomics and Health
Macroeconomics
and Health: Investing in Health and Economic Development (December
2001)
Consumer Project on Technology
World
Trade Organization: Issues Involving Health Care and Intellectual
Property Disputes
Useful collection of documents, letters, statements, press releases,
WTO documents, National Positions on TRIPS and Access to Medicines,
Post Doha
International Centre for Trade and Sustainable Development
(ICTSD)
Collection
of Documents on TRIPS and Access to Medicines in Developing Countries
International Federation of Pharmaceutical Manufacturers
Associations
TRIPS,
Pharmaceuticals and Developing Countries: Implications for Health
Care Access, Drug Quality and Drug Development
Médecins Sans Frontières (MSF)
Journal of International Economic Law
The
Doha Declaration on the TRIPS Agreement and Public Health: Lighting
a Dark Corner at the WTO By Frederick M. Abbott (2 September,
2002)
Pharmaceutical Research and Manufacturers of America
The
Case for Innovation: The Role of Intellectual Property Protection
Alan F. Holmer President and Chief Executive Officer Pharmaceutical
Research and Manufacturers of America The Economist’s Second
Annual Pharmaceuticals Roundtable Philadelphia, Pennsylvania November
20, 2002
Journals The Lancet
Out-licensing:
a practical approach for improvement of access to medicines in poor
countries Michael A Friedman, Henk den Besten, Amir Attaran
Lancet 2003; 361: 341-44 (Requires Registration and Subscription).
|
